Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)

China flag China · Delayed Price · Currency is CNY
10.85
+0.02 (0.18%)
At close: Mar 9, 2026
-2.25%
Market Cap 14.55B
Revenue (ttm) 9.36B
Net Income (ttm) 944.38M
Shares Out 1.34B
EPS (ttm) 0.70
PE Ratio 15.41
Forward PE n/a
Dividend 0.30 (2.77%)
Ex-Dividend Date Sep 16, 2025
Volume 17,380,200
Average Volume 10,575,632
Open 10.72
Previous Close 10.83
Day's Range 10.71 - 10.99
52-Week Range 9.69 - 11.80
Beta 0.33
RSI 57.58
Earnings Date Mar 28, 2026

About SHA:600420

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers 6-APA, potassium clavulanate series, diclofenac sodium extended release tablets, urine-derived biochemical products, nifedipine controlled release tablets, azithromycin, ceftriaxone sodium for injection, methylprednisolone sodium succinate for injection, cefuroxime tablets/capsules, ampicillin acid, penicillin industrial potassium salt, Touboke Yuekui granules/capsules, remifentanil hydr... [Read more]

Sector Healthcare
Founded 2000
Employees 11,472
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600420
Full Company Profile

Financial Performance

In 2025, SHA:600420's revenue was 9.36 billion, a decrease of -14.40% compared to the previous year's 10.94 billion. Earnings were 944.38 million, a decrease of -12.85%.

Financial Statements

News

There is no news available yet.